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Antimicrobial chemotherapy is critical in the fight against infectious diseases caused
by Entamoeba histolytica. Among the drugs available for the treatment of amebiasis,
metronidazole (MTZ) is considered the drug of choice. Recently, in vitro studies have
described MTZ resistance and the potential mechanisms involved. Costs to fitness and
adaptive responses associated with resistance, however, have not been investigated. In
this study we generated an HM-1 derived strain resistant to 12µM MTZ (MTZR). We
examined its phenotypic and transcriptional profile to determine the consequences and
mRNA level changes associated with MTZ resistance. Our results indicated increased
cell size and granularity, and decreased rates in cell division, adhesion, phagocytosis,
cytopathogenicity, and glucose consumption. Transcriptome analysis revealed 142
differentially expressed genes in MTZR. In contrast to other MTZ resistant parasites,
MTZR did not down-regulate pyruvate:ferredoxin oxidoreductase, but showed increased
expression of genes for a hypothetical protein (HP1) and several iron-sulfur flavoproteins,
and downregulation of genes for leucine-rich proteins. Fisher’s exact test showed 24
significantly enriched GO terms in MTZR, and a 3-way comparison of modulated genes
in MTZR against those of MTZR cultured without MTZ and HM-1 cultured with MTZ,
showed that 88 genes were specific to MTZR. Overall, our findings suggested that MTZ
resistance is associated with specific transcriptional changes and decreased parasite
virulence.
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Introduction
Currently, 500 million cases of amebiasis are reported each year (World Health Organization
Amoebiasis, 1997). Most of these cases are children from developing nations, who are particularly
vulnerable to infectious diseases (Marie and Petri, 2014). Among the drugs available for the
treatment of amebic dysentery and amebic liver abscess, metronidazole (MTZ) is one of the most
widely used, and is often considered the drug of choice (Löfmark et al., 2010). Treatment withMTZ
is usually very effective, i.e., no clinical isolates with high levels of resistance have been observed.
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However, reports of patients refractory to the drug are
documented (Koutsaimanis et al., 1979; Dooley and O’Morain,
1988). In addition, in vitro studies on the induction of
MTZ resistance in Entamoeba histolytica are described
(Samarawickrema et al., 1997; Wassmann et al., 1999).
Coincidentally, clinical and in vitro resistance to the drug
in Trichomonas vaginalis (Müller et al., 1980; Wright et al.,
2010), Giardia lamblia (Müller et al., 2007; Tejman-Yarden
et al., 2011), Blastocystis spp. (Mirza et al., 2011a,b), Neisseria
gonorrhoeae (Yoshikawa et al., 1974), and several anaerobic
bacteria (Pumbwe et al., 2007; Peláez et al., 2008; Tanih et al.,
2011) have also been reported since the drug was introduced in
1960 (Figure S1) (Durel et al., 1960). Based on these findings, it is
reasonable to assume that clinical resistance to MTZ might soon
be reported in E. histolytica.
Unlike aerobic cells, anaerobic organisms are sensitive to
MTZ because their electron transport proteins have sufficient
negative redox potential that can activate MTZ (Samuelson,
1999). After entering the cell, the drug is reduced to a cytotoxic
nitro radical anion by electron donors like thioredoxin reductase
and ferredoxin (Fdx), which in turn serve as electron acceptors
for pyruvate:ferredoxin oxidoreductase (PFOR) (Samuelson,
1999; Leitsch et al., 2007). The nitro radical anion is reduced
further to a nitrosoimidazole, and further reduction leads to
the formation of hydroxylamine and eventually to an amine
(West et al., 1982; Moreno and Docampo, 1985; Ludlum et al.,
1988). In E. histolytica, the actual mechanism of action is not
fully understood, but evidences from other organisms suggest
inhibition of DNA synthesis, and damage to DNA, protein,
and other cell components by oxidation and adduct formation
(Ludlum et al., 1988; Sisson et al., 2000; Leitsch et al., 2007).
A few mechanisms have been proposed to explain how
pathogens survive MTZ treatment. The process varies among
organisms, but the general principle includes at least one of
the following: altered reduction efficiency (Leiros et al., 2004),
drug inactivation (Ralph and Clarke, 1978), reduced drug uptake
(Lacey et al., 1993), active eﬄux (Pumbwe et al., 2007), and
increased DNA damage repair (Land and Johnson, 1999). In E.
histolytica, Samarawickrema et al. (1997) reported the increased
expression of iron-containing superoxide dismutase (Fe-SOD) in
a strain resistant to 10µM MTZ, while Wassmann et al. (1999)
showed that in addition to Fe-SOD upregulation, resistance to
40µM MTZ was associated with increased peroxiredoxin (Prx)
expression and decreased expression of Fdx. On the contrary,
Tazreiter et al. (2008) showed no substantial increase in Fe-SOD
expression and less than 3-fold upregulation of Fdx and Prx in
cells exposed to 50µM MTZ. In addition, all three studies did
not find any significant changes in PFOR expression, indicating
that its downregulation may not be mandatory for low to modest
drug resistance in this parasite. Studies on MTZ resistance in T.
vaginalis and G. lamblia also showed variable results regarding
the role of PFOR (Quon et al., 1992; Rasoloson et al., 2002;
Müller et al., 2008; Leitsch et al., 2011). Strains of T. vaginalis
deficient in PFOR activity, for example, showed only low levels
of anaerobic resistance to MTZ (Rasoloson et al., 2002). In
addition, some clinical strains exhibited resistance only under
aerobic conditions, and were completely sensitive to MTZ in the
absence of oxygen (Rasoloson et al., 2002). These strains also
showed no decrease in PFOR activity (Rasoloson et al., 2002).
Other reports, however, have shown decreased Fdx levels inMTZ
resistant trichomonads (Ralph et al., 1974; Yarlett et al., 1986) and
anaerobic resistance that was correlated with decreased PFOR
activity (Kulda et al., 1989). From these results, it is conceivable
that different pathways are involved in drug activation, and that
various mechanisms for MTZ resistance exist in protozoa.
Currently, most of the work done in E. histolytica focused
either on pathways known to activate, i.e., chemically reduce,
MTZ (Leitsch et al., 2007) or antioxidants that counteract
oxidative stress, such as pyruvate:ferredoxin oxidoreductase,
superoxide dismutase, and peroxiredoxin (Samarawickrema
et al., 1997; Wassmann et al., 1999). Fitness costs and adaptive
responses have not yet been examined. In this study we generated
an E. histolyticaHM-1-derived isogenic strain resistant to 12µM
MTZ (MTZR). By comparing its phenotype and transcriptional
profile against the parental strain, our goal was to identify
phenotypic and transcriptional changes related to or involved
in MTZ resistance. We compared the transcriptome of a single
MTZR line cultured with MTZ [MTZR (+)] against MTZR
cultured without the drug [MTZR (−)], and HM-1 exposed to
MTZ [HM-1 (+)] to determine the significance of the genes we
identified. Finally, to verify their involvement in resistance, some
genes were overexpressed by episomal transfection, followed by
drug challenge.
Materials and Methods
Chemicals and Reagents
MTZ, ornidazole, emetine, chloroquine, paromomycin, L-
cysteine, and N-(trans-Epoxysuccinyl)-L-leucine 4-guanidinobut
ylamide (E-64) were purchased from Sigma-Aldrich (St. Louis,
MO, USA), while tinidazole was acquired from LTK Laboratories
(St. Paul, MN, USA). DNAzol reagent, TRIzol reagent, PLUS
reagent, Lipofectamine, and geneticin (G418) were secured from
Invitrogen (Carlsbad, CA, USA). All other chemicals were
obtained from Wako Pure Chemical Industries (Osaka, Japan)
unless otherwise stated. Drugs were dissolved either in distilled
water or dimethyl sulfoxide (DMSO) to a stock concentration of
100mM and stored at−30◦C.
Cultivation and Induction of MTZ Resistance
E. histolytica strain HM-1:IMSS cl6 (HM-1) (Diamond et al.,
1972) was cultured under axenic conditions in 6mL BI-S-33
medium (BIS) at 35.5◦C in 13× 100mm Pyrex screw cap culture
tubes (Corning, Corning, NY) (Diamond et al., 1978). Induction
of MTZ resistance was initiated when cells in mid-logarithmic
phase of growth were exposed to 1µM of the drug until late
logarithmic phase. In this study, cultures with cell concentrations
between 4 × 104 and 2 × 105/mL were considered to be in
mid-logarithmic phase, and corresponds to cell densities after
1 and 2 days, respectively, after the cultures were initiated with
at 2–5 ×104 trophozoites per mL. The drug concentration was
increased by 1µM until it reached 4µM. Cells were maintained
with the same dose for 4 weeks before further increase in
drug concentration was made. A strain growing at 12µM MTZ
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[MTZR (+)] was obtained approximately after 28 weeks, and
was used in all experiments. MTZR was also cultured without
the drug [MTZR (−)] for 24 h up to 1 week when we tested for
reversibility of resistance and when samples were prepared for
microarray.
Cultivation of Chinese Hamster Ovary (CHO)
Cells
CHO cells, a gift from Dr. Kentaro Hanada, were cultured
in Ham’s F-12 medium (GIBCO, Invitrogen Co., Auckland,
New Zealand) with 10% fetal calf serum (Medical Biological
Laboratory International, Woburn, MA, USA) in 25 cm2 canted
neck culture flasks (IWAKI, Tokyo, Japan) at 37◦C with
humidified air and 5% CO2.
Growth Kinetics
After trophozoite cultures in mid-log phase of HM-1 and MTZR
were placed on ice for 5min to detach cells from the glass surface,
cells were collected by centrifugation 500 × g for 5min at room
temperature. After centrifugation, spent medium was discarded
and the pellet was resuspended in 1–2mL of BIS medium. The
cell number was estimated on a haemocytometer. Approximately
6×104 trophozoites were inoculated in 6mL BISmediumwith or
without 12µMMTZ, and the cultures were examined every 24 h
for 5 days. Trypan blue exclusion assay was used to determine the
number of viable cells in duplicate cultures (Penuliar et al., 2011).
Half Maximal Inhibitory Concentration (IC50) and
Cross-Resistance
Trophozoites in mid-log phase of HM-1 and MTZR were
harvested, resuspended in BIS medium as described above, and
the concentration was adjusted to 1×105 cells/mL. About 1×104
cells in 100µL BIS were seeded per well of a 96-well microtiter
plate (Iwaki, Tokyo, Japan) and incubated at 35.5◦C for 1 h under
anaerobic conditions using Anaerocult A (Merck, Darmstadt,
Germany). One hundred microliters of BIS containing 2-fold
increases in concentration of the drugs listed in Table 1 was
added, and the plates incubated for 24 and 48 h. The medium
was removed and replaced with 200µL 10% WST-1 reagent
(Roche, Indianapolis, IN, USA) in phosphate-buffered saline
(PBS) and the plates incubated for 20–40min. Optical density
at 450 nm was measured using a DTX 880 Multimode Detector
(Beckman Coulter, Fullerton, CA, USA). The percentage of viable
cells was calculated after subtraction of background absorbance
as % viability = (absorbance of treated cells/absorbance of
untreated cells) × 100%. IC50 values were calculated using
the sigmoidal dose-response equation in GraphPad Prism 5.0
(GraphPad Software, La Jolla, CA, USA). All experiments were
repeated three times with two replicates per experiment. To assay
the hydrogen peroxide sensitivity of the transformants harboring
one of the following plasmids: HP1-HA, ISF1-HA, ISF2-HA,
ISF4-HA, and pEhEx-HA, about 1 × 104 cells were seeded per
well of a 96-well microtiter plate and incubated at 35.5◦C for 12–
16 h under anaerobic conditions. The cells were then exposed to
25–1600µM of hydrogen peroxide for 4 h. Then the cell viability
was measured by using WST-1 reagent as described above.
TABLE 1 | IC50 of drugs used to treat amebiasis and hydrogen peroxide in
HM-1 and MTZR.
Compound Description HM-1 MTZR RIa
Chloroquine Amebicide 1562.7±0.3 3125.3± 0.4 2.0
Emetine Amebicide 12.8±0.3 50.3± 0.3 3.9
Metronidazole Amebicide 6.5±0.3 12.9± 0.3 2.0
Ornidazole Amebicide 6.5±0.3 12.3± 0.3 1.9
Paromomycin Amebcide 12.6±0.4 25.1± 0.3 2.0
Tinidazole Amebicide 12.6±0.2 24.9± 0.3 2.0
Hydrogen peroxide Stress inducer 244.2±0.4 488.1± 0.3 2.0
aResistance index values are determined by dividing the IC50 of drug in MTZR by that in
HM-1.
CHO Monolayer Destruction Assay
Rate of CHO monolayer destruction was measured as described
previously with minor modifications (Penuliar et al., 2011).
Briefly, CHO cells in logarithmic phase of growth were prepared
as follows. After spent medium was discarded, CHO cells were
incubated with trypsin-EDTA at 37◦C for 5min to detach
cells. Cells were transferred to a 50mL tube containing 5mL
of Ham’s F-12 medium and cell density was estimated on a
haemocytometer. Cells were collected by centrifugation at 500
× g for 10min at room temperature. After the supernatant was
discarded, the cell pellet was re-suspended inHam’s F-12medium
at 1 × 105 CHO cells per mL. Approximately 100µL of the
CHO suspension was dispensed into each well on a 96-well
plate and the plate was incubated at 37◦C as described (Penuliar
et al., 2011) for 24–48 h until CHO cells form a monolayer. The
medium was removed and the plates washed twice with warm
PBS. Approximately 1 × 104 cells of HM-1 and MTZR were
resuspended in 200µL Opti-MEMmedium (GIBCO, Invitrogen
Co., Auckland, New Zealand) and added to each well. The
plates were incubated under anaerobic conditions at 35.5◦C
for 15min intervals up to 2 h. The plates were placed on ice
for 15min to release adhered trophozoites and washed twice
with cold PBS. The percentage of CHO monolayer destroyed
was determined relative to wells without the ameba using 10%
WST-1.
Substrate Gel Electrophoresis
Proteinase activity was detected by substrate gel electrophoresis
as described previously (Hellberg et al., 2000). Briefly, 20µg
of cell lysate from HM-1 and MTZR strains were separated in
a 12% [w/v] sodium dodecyl sulfate (SDS)-polyacrylamide gel
copolymerized with 0.1% [w/v] gelatin. The gel was incubated
in 2.5% [v/v] Triton X-100 for 1 h and then in 100mM sodium
acetate, pH 4.5, 1% [v/v] Triton X-100, and 20mM dithiothreitol
for 3 h at 37◦C. Bands were visualized after staining with 0.5%
[w/v] Coomassie Brilliant Blue R-250.
Phagocytosis Assay
Trophozoites of HM-1 and MTZR in mid-logarithmic phase of
growth were harvested, resuspended in BIS medium as described
above, and the concentration was adjusted to 1 × 106 cells/mL.
Approximately 1.0 × 106 of HM-1 and MTZR trophozoites
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were seeded on each well of 12-well plates. Spent medium was
removed and replaced with 500µL warmed BIS with 1.5 × 107
FluoSpheres carboxylate-modified (2.0µm) Nile Red fluorescent
beads (Invitrogen, Eugene, OR, USA). The plates were sealed and
incubated at 35.5◦C for up to 80min. After incubation, 500µL of
PBS containing 2% galactose was added and the plates incubated
on ice for at least 20min. Formaldehyde was added to a final
concentration of 4% and plates incubated on ice for 1 h. The cells
were collected, washed three times with cold PBS and analyzed
by flow cytometry as previously described (Nakada-Tsukui et al.,
2005). Cells that ingested the beads were gated based on increased
fluorescence compared to control non-phagocytic cells.
Glucose Consumption
Trophozoites of HM-1 and MTZR in mid-logarithmic phase of
growth were harvested, resuspended in BIS medium as described
above, and the concentration was adjusted to 1 × 107 cells/mL.
Approximately 1 × 107 cells were seeded in 6-well dishes and
incubated for 12 and 24 h. Spent medium was decanted and
centrifuged at 500 × g for 5min. Glucose consumption was
determined from the clarified medium using a Glucose (GO)
Assay kit (Sigma Aldrich, Saint Louis, MO, USA) according to
manufacturer’s protocol.
Estimation of Total Protein Amount in a
Single Cell
Trophozoites of HM-1 and MTZR in mid-logarithmic phase of
growth were harvested as described above. Cell pellet was re-
suspended in PBS at 1 × 106/mL. Approximately 500µL of the
cell suspension were dispensed to a 1.5mL tube and the cells were
collected by centrifugation at 500 × g for 3min at 4◦C. After the
supernatant was carefully removed, the cell pellet was lysed with
50µL of lysis buffer [50mM Tris-HCl, pH 7.5, 150mM NaCl,
1% Triton-X 100, complete mini EDTA-free protease inhibitor
cocktail (Roche Molecular Biochemicals, Mannheim, Germany)
and 200mM E-64]. Protein amount of the lysate were quantified
by DC protein assay kit (Bio-Rad Laboratories, Inc., Hercules,
CA, USA).
RNA Isolation
HM-1 and MTZR were cultured with and without 12µM
MTZ in 25 cm2 tissue culture flasks. HM-1 cultured with the
drug was incubated for 5 h [(HM-1 (+)], while MTZR without
MTZ was maintained for 1 week [(MTZR (−)]. Except for
HM-1 (+), the spent medium for all other cultures were
removed and replaced with fresh BIS with and without the
drug and the flasks incubated at 35.5◦C for 5 h. Total RNA was
extracted with TRIzol Reagent according to the manufacturer’s
instructions for cells grown in monolayers; cleaned with RNeasy
kit (Qiagen, Hilden, Germany), and assessed for quality with
the Experion automated electrophoresis system and Experion
RNA StdSens analysis kit (Bio-Rad Laboratories, Inc., Hercules,
CA, USA). RNA quantity was determined by measuring
the absorbance at 260 nm with NanoDrop ND-1000 UV-Vis
spectrophotometer (NanoDrop Technologies, Wilmington, DE,
USA).
Microarray Hybridization
Samples from two independent RNA extractions were processed
using Ambion MessageAmpTM Premier RNA Amplification
Kit (Applied Biosystems, Foster City, CA, USA) according
to manufacturer’s instructions. Fragmented cRNA was then
hybridized onto a probe array chip (Eh_Eia520620F) that was
custom-made by Affymetrix (Santa Clara, CA, USA) (Husain
et al., 2011; Penuliar et al., 2012) using kits and protocols
specified in the Affymetrix GeneChip Expression Analysis
TechnicalManual (Affymetrix, Santa Clara, CA, USA). Following
hybridization, arrays were washed, stained with streptavidin-
phycoerythrin (Molecular Probes, Eugene, OR, USA) using
Affymetrix GeneChip Fluidics Station 450, and scanned with an
Affymetrix GeneChip Scanner 3000 at 570 nm. Each array image
was visually screened to check for scratches, signal artifacts, and
debris.
The microarray used in this study was made based on
E. histolytica and E. invadens sequences stored at TIGR and
Pathema databases (Loftus et al., 2005; http://amoebadb.org/
amoeba/). It contained 9230 probe sets for E. histolytica and
an additional 25 and 81 control probe sets for Entamoeba and
Affymetrix, respectively (Eh_Eia520620F_Eh). Nomenclature
for the IDs was based on whether the probe set is unique to
either Pathema (e.g., EHI_123456) or TIGR (e.g., 12.m00345),
or is found in both databases (e.g., 98.m00765_234567). Probe
sets labeled with “_at” represent a single gene, while those
labeled with “_s_at” represent probe sets that share all probes
identically with at least two sequences. The “_s_at” probe sets
represent highly similar transcripts, shorter forms of alternatively
polyadenylated transcripts, or common regions in the 3′ ends
of multiple alternative splice forms. Probe sets labeled with
“_x_at,” on the other hand, represent probe sets where it was
not possible to select either a unique probe set or a probe set
with identical probes among multiple transcripts. These probe
sets could cross-hybridize with other genes in an unpredictable
manner (Affymetrix, Santa Clara, CA, USA).
Data Normalization, Analysis, and Deposition
Raw probe intensities were generated by the GeneChip
Operating Software (GCOS) and GeneTitan Instrument
from Affymetrix. Resulting expression values were analyzed
by R/BioConductor and GeneSpring GX Ver.11.5 to identify
differentially expressed genes. Reproducibility of the experiments
was determined by Pearson’s correlation coefficient and
confirmed by principal component analysis (Pearson, 1901;
Stigler, 1989). Only genes that were considered “present” by
GCOS in both arrays were used in further analysis. Gene
probe sets were considered differentially expressed between
samples if they had at least a 3-fold change and a P-value
< 0.05, calculated using Welch’s t-test (Welch, 1947), after
multiple test correction by the Benjamini–Hochberg method
(Benjamini and Hochberg, 1995). A post-hoc test using Tukey’s
Honestly Significant Difference test was conducted to determine
significant differences between samples (Tukey, 1949). Probe
sets ending with “_x_at” were removed together with redundant
genes identified by sequence alignment using ClustalW2.48
Finally, RefSeq’s annotated pseudogenes were omitted from
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the final list (ClustalW2; http://www.ebi.ac.uk/Tools/msa/
clustalw2/).
Nucleotide sequences of differentially expressed genes
were searched against GenBank (http://www.ncbi.nlm.nih.
gov/genbank/) and Amoeba DB (http://amoebadb.org/
amoeba/) by using Basic Local Alignment Search Tool
(BLAST; http://blast.ncbi.nlm.nih.gov/Blast.cgi). Matches
against hypothetical proteins (HP) with E-value < e−50 and
maximal scoring pair alignment that covered at least 40%
were considered as putative orthologs (McLysaght et al.,
2003). Hierarchical clustering of modulated genes in MTZR,
MTZR (−), and HM-1 (+) was performed with Cluster 3.0
(http://bonsai.hgc.jp/∼mdehoon/software/cluster/software.htm)
using average linkage, while dendrograms and heatmaps
were generated with Java TreeView version 1.1.6r2. (http://
jtreeview.sourceforge.net) Gene Ontology (GO) annotations
were mined from the Gene Ontology Annotation Database
(http://www.ebi.ac.uk), and Amoeba DB. GO term enrichment
was computed using Fisher’s exact test (Agresti, 1992), against
a background consisting of all GO IDs for genes symbols
beginning with EHI, which were downloaded from the QuickGO
database of European Molecular Biology Laboratory - European
Bioinformatics Institute (EMBL-EBI) (Taxon ID: 5759) (http://
www.ebi.ac.uk/QuickGO/). Genomic location of each gene was
obtained from Pathema-Entamoeba (http://pathema.jcvi.org)
while transmembrane domain prediction was performed using
the following online servers: HMMTOP (http://www.enzim.
hu), SOSUI (http://bp.nuap.nagoya-u.ac.jp), TMHMM (http://
www.cbs.dtu.dk), TopPred (http://mobyle.pasteur.fr), TMpred
(http://www.ch.embnet.org), and Phobius (http://phobius.sbc.
su.se). Signal peptide sequences were predicted using SignalP
(http://www.cbs.dtu.dk), SOSUIsignal (http://bp.nuap.nagoya-u.
ac.jp), and Phobius. Putative transmembrane domains and signal
peptides were considered present only if positive hits were found
in all programs used. Venn diagrams were constructed using
Venn Diagram Generator (http://www.pangloss.com/seidel/
Protocols/venn.cgi).
The microarray data reported in this paper has been deposited
in the Gene Expression Omnibus (GEO) database (http://www.
ncbi.nlm.nih.gov/geo/) with accession number GSE35990.
Generation of Transgenic Ameba Overexpressing
HP1 and ISFs
Full-length gene sequences were amplified from MTZR cDNA
with sense- and anti-sense primers containing appropriate
restriction sites (Table S2). PCR primers were designed as follows:
sense primers contained 26∼30 nucleotides corresponding to
a region of each gene encoding the amino-terminal portion
of each target proteins, fused at the 5′ end with three
additional nucleotides and SmaI restriction enzyme recognition
site (tccCCCGGG); reverse primers contained 22∼33 nucleotides
corresponding to a region of each gene encoding the carboxyl-
terminal portion of each target proteins, fused at the 5′ end
with three additional nucleotides and XhoI restriction enzyme
recognition site (ccgCTCGAG). PCR was performed with the
cDNA as a template using a DNA Engine Peltier Thermal Cycler
(Bio-Rad, Hercules, CA, USA). The PCR cycling conditions
consisted of an initial step of denaturation at 94◦C for 1min,
followed by 30 cycles of denaturation at 98◦C for 10 s, annealing
at 55◦C for 30 s, and extension at 72◦C for 60 s with PhusionDNA
polymerase (New England BioLabs, Tokyo, Japan). Resultant
PCR fragments were precipitated with ethanol, digested with
appropriate restriction enzymes, and then purified from an exised
piece of agarose gel by using GENECLEAN kit (Funakoshi,
Tokyo, Japan). After purification, the gene was inserted into an
expression plasmid, pEhEx, as previously described (Penuliar
et al., 2012). The plasmid was introduced into E. histolytica G3
strain by lipofection, with minor modifications as previously
described (Penuliar et al., 2012). Briefly, E. histolytica G3
trophozoites in the mid- logarithmic growth phase were
harvested as described above, and re-suspended with Opti-MEM
medium supplemented with 5mg/mL L-cysteine and 1mg/mL
ascorbic acid at 1 × 105 cells/mL. Approximately 5mL of the
suspension was dispensed into each well on a 12-well plate and
the plate was incubated under anaerobic condition at 35.5◦C
for 30min. Following incubation, 4.5mL medium from each
well was removed and 500µL liposome–plasmid–mixture (5µg
plasmid, 10µL PLUS reagent, 20µL Lipofectamine in Opti-
MEM medium) was added. After 5 h of transfection, cells were
harvested by placing the plate on ice for 15min, then added
to culture tubes with 5.5mL cold BIS, and incubated at 35.5◦C
for 24 h. Transformants were initially selected in the presence
of 1µg/mL of G418, and drug concentration was gradually
increased to 10µg/mL during the following 6 weeks before the
transformants were analyzed.
Reverse Transcriptase (RT)-PCR and Quantitative
Real-Time (qRT)-PCR
Total RNA from semi-confluent cultures, about 2×105 cells/mL,
of HM-1, MTZR, and transformants harboring one of the
following plasmids: pEhEx-HA (mock plasmid), HP1-HA, ISF1-
HA, ISF2-HA, and ISF4-HA, cultured in 25 cm2 flasks, was
extracted and quantified as described previously (Penuliar et al.,
2012). cDNA was reverse transcribed from 5µg RNA with the
SuperScript III First-Strand Synthesis System, and RT-PCR was
performed with the resulting cDNA as template and primers
listed in Table S2 on a DNA Engine Peltier Thermal Cycle
(Bio-Rad Laboratories, Inc., Hercules, CA, USA). The PCR
parameters used were: an initial denaturation step at 95◦C for
2min followed by 30 cycles of denaturation at 94◦C for 15 s,
annealing at 55◦C for 30 s, and extension at 72◦C for 30 or
60 s. The products were resolved on 1.5% [w/v] agarose gel
with 0.5µg/mL ethidium bromide, visualized, and photographed
under ultraviolet illumination.
The Fast SYBRGreenMaster Mix (Applied Biosystems, Foster
City, CA, USA) was used for qRT-PCR in accordance with the
manufacturer’s instructions. The list of primers for genes whose
expression was quantified by qRT-PCR can be found in Table
S1, and includes a housekeeping gene, RNA polymerase II gene
(rpoII), as control. Each PCR reaction contained 5µL (1:50
dilution) of cDNA and 15µL primer mix, composed of 10µL 2X
Fast SYBR Green Master Mix, sense and antisense primers, and
nuclease-free water, to bring the volume to 20µL. qRT–PCR was
performed using StepOne Plus Real-Time PCR System (Applied
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Biosystems, Foster City, CA, USA) with the following cycling
conditions: enzyme activation at 95◦C for 20 s, followed by 40
cycles of denaturation at 95◦C for 3 s and annealing/extension at
60◦C for 30 s. All test samples were run in triplicate including
an RT-negative control for each sample set along with a blank
control consisting of nuclease-free water in place of cDNA.
Quantification for each target gene was determined by the11Ct
method with rpoII as reference gene (Livak and Schmittgen,
2001).
Statistical Analysis
Correlation coefficients were calculated using the Student’s t-
test function of Microsoft Excel statistical package (Microsoft
Corp., Redmond, WA, USA). Probability levels (P) < 0.05 were
considered significant.
Results
Generation and Phenotypic Characterization of
MTZR
Exposure of HM-1 to MTZ concentrations up to 3µM for 24 h
did not result in any significant changes in cell morphology. Cells
continued to grow and cultures formed confluent lawns after
72 h. Starting at 6µMMTZ, however, cells became rounder than
usual and were slightly bigger in size. Cells also took longer to
attach to surfaces and for cultures to form confluent lawns. Cell
viability, however, was verified by cell adhesion and trypan blue
exclusion assay. After 29 weeks, cells growing at 12µM MTZ
(MTZR) were obtained. We tried to increase the concentration
of MTZ further, but this resulted in further increase in doubling
time.
The population doubling time of MTZR was significantly
longer compared to HM-1 (26.8 ± 0.9 and 18.2 ± 0.5 h,
respectively; P-value < 0.001, Figure 1). MTZR also appeared
rounder, bigger, and more granular than HM-1. In contrast,
parental cells exposed to 12µM MTZ showed signs of
morphological changes as early as 2 h, rounding in 5 h, cell
shrinkage, and detachment within 24 h. The slight enlargement
of MTZR (+) compared to HM-1 was suggested when we
measured the total protein content of MTZR and HM-1, 4.81
± 0.04 and 4.24 ± 0.03 pg/cell, respectively. Flow cytometric
analysis also confirmed that MTZR was slightly larger than
HM-1 (data not shown).
The IC50 of MTZ in MTZR and HM-1 was 12.9 ± 0.3 and
6.5 ± 0.3µM, respectively, and its resistance index was 2.0
(Table 1). When MTZR was cultured without the drug for 1
week followed by MTZ challenge for 24 h, percent survival was
only 28%, indicating that resistance to the drug was reversible
(data not shown). To determine if MTZRwas cross-resistant with
other amebicides, the IC50 of the drugs listed in Table 1, against
MTZR and HM-1 was determined. Results showed that MTZR
had reduced sensitivity to the drugs.
MTZR had a slower rate of CHO monolayer destruction,
especially at early time points, indicating a slight decrease in
virulence (P-value < 0.05 for 30, 45, 60, and 75min; Figure 2A).
This was consistent with the observed decrease in intensity of
bands corresponding to cysteine protease 1 and 2 (CP1 and
FIGURE 1 | Growth kinetics of HM-1 (circles) and MTZR (triangles)
cultured with (open symbols) or without (filled symbols) 12µM MTZ.
CP2, synonymous to EhCP-A1 and EhCP-A2, respectively) in
the zymogram (Figure 2B), and by an ImageJ (http://rsbweb.
nih.gov/ij/) analysis of the same bands that indicated an
approximately 33% decrease in band areas. The band for CP5
(EhCP-A5) and control bands (arrow head) were comparable
between HM-1 and MTZR. The decrease in cytopathy in MTZR
was also indicated by the lower the number of engulfed beads
(Figure 2C) and percentage of cells with engulfed beads in the
phagocytosis assay (Figure 2D). MTZR also consumed glucose at
a reduced rate compared toHM-1 (P-value< 0.05, Figure 2E). In
addition, MTZR adhered to plastic surfaces, and to fibronectin-
and collagen-coated plates at relatively comparable levels, but not
as efficiently as HM-1 (Supplementary Figure S2).
Transcriptomic Analysis of MTZR
Our expression data showed variations in the number of
differentially expressed genes betweenMTZR andHM-1 cultured
with and without MTZ (GEO ID: GSE35990). To identify genes
whose expression was most highly affected, a general filtering
of the expression data, as indicated in Materials and Methods,
was used. This resulted in the identification of 142 probe sets
for MTZR, 58 probe sets for MTZR (−), and 37 probe sets for
HM-1 (+) that showed at least 3-fold changes compared to HM-
1 (−) (Figure 3A, Table S3). In MTZR, 95 (66.9%) of the genes
were upregulated, while 47 (33.1%) genes were downregulated
(Tables 2, 3). Only 55 (38.7%) genes were annotated after
conducting BLAST search, while 87 (61.3%) genes encoded for
proteins of unknown function, i.e., hypothetical proteins (Table
S4). The most upregulated gene was a hypothetical protein (HP)
(EHI_006850) with some similarity to a zinc finger protein in E.
histolytica (E-value = 1.0e−46), designated as HP1 in this study.
Its expression in MTZR was increased by 36.9 folds. Genes for
DNA polymerase (EHI_164190), iron-sulfur flavoprotein (ISF)
(EHI_025710), AIG1 family protein [XP_648192 (522.m00018)],
and four other HPs were also upregulated by more than 10
folds. The most downregulated genes were three leucine-rich
proteins [EHI_033560, EHI_077280, EHI_124070 (371.m00031)]
which had fold changes of more than 160, and two AIG family
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FIGURE 2 | Phenotypic changes observed in MTZR. Statistical
significance is indicated (P-value < 0.05). (A) CHO monolayer
destruction assay of HM-1 (black bars) and MTZR (gray bars). (B)
Zymography of whole cell lysates of HM-1 and MTZR. An arrowhead
indicates comparable protein loading per lane as estimated by CBB
staining of irrelevant proteins. (C,D) Phagocytosis assay with
carboxylated beads in HM-1 (black bars) and MTZR (gray bars). The
number of beads phagocytosed (C) and the percentage of cells with
engulfed beads (D) at indicated time points are compared between
HM-1 and MTZR. (E) Glucose consumption assay.
proteins [XP_648014 (628.m00011), EHI_180390] and two CPs
(EHI_160330, EHI_121160) genes that were downregulated by
at least 5 folds. The two CPs identified had high similarity to
CP7 (synonymous to EhCP-B1) (81%) based on amino acid
sequence (Tillack et al., 2007). The differential expression of 16
genes was validated by qRT-PCR, using rpoII as an endogenous
control (Table 4). Pearson’s correlation coefficient (0.81) between
microarray and qRT-PCR results indicated a reasonable degree of
concordance between the fold-changes of the genes selected for
this comparison.
To determine whether the genes we identified were important
in MTZ resistance or resulted from a general stress response, a
3-way comparison of differentially expressed genes in MTZR,
MTZR (−) and HM-1 (+) was performed. Figures 3A,B,
and Table S3 show that out of 142 genes modulated in
MTZR, 48 genes (33.8%) were also modulated in MTZR
(−), while only 8 genes (5.6%) were differentially transcribed
in HM-1 (+). Among the genes specifically modulated
in MTZR were DNA polymerase (EHI_164190), 4 AIG1
family proteins [EHI_026000, EHI_126550, EHI_126560,
XP_648127 (554.m00020)], four iron-sulfur flavoproteins
(EHI_022270, EHI_022600, EHI_181710, EHI_067720,
EHI_103260), metal-dependent hydrolase (EHI_054690), dUTP
nucleotidohydrolase domain-containing protein (EHI_072960),
three serine-rich 25 kDa antigen protein [EHI_073980,
EHI_072000, EHI_072000 (82.m00164)], two Ras family protein
(EHI_074750, EHI_045600), Rho guanine nucleotide exchange
factor (EHI_006140), and a competence/damage-inducible
protein (EHI_090260). In MTZR (−), AP-2 complex protein
(EHI_014390), serine acetyltransferase (EHI_021570), zinc
finger protein (EHI_091050), cysteine protease (EHI_117650),
and a cell division control protein (EHI_154270) were specifically
modulated. In HM-1 (+), on the other hand, genes for heat
shock proteins [EHI_005657 (181.m00064), EHI_156560
(482.m00014), EHI_034710)] were specifically upregulated
together with genes putatively involved in drug resistance
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FIGURE 3 | Venn diagram (A) and heat map (B) of modulated genes in MTZR, MTZR (−), and HM-1 (+). Note that most of genes that were transcriptionally
regulated in MTZR were specific to the strain when cultured with MTZ.
like P-glycoprotein 5 (EHI_075410, EHI_125030) and ATP-
binding cassette protein (EHI_134470, EHI_178580). Two
iron-sulfur flavoproteins (EHI_025710, EHI_138480) and an
ABC transporter [EHI_084730 (36.m00218)] were upregulated
in both MTZR and HM-1 (+), although their expression in HM1
(+) was 2 to 3 folds higher. It is also interesting to note that in
all three strains, induction of gene transcription clearly prevailed
over inhibition. This was particularly true for HM-1 (+) where
almost 95% of the modulated genes were upregulated.
Go Classification, Features, and Clustering on
the Genome
To have a general view of the cellular functions regulated as
a result of MTZ resistance, we performed a GO enrichment
analysis. A total of 132 GO terms were mined from Amoeba DB
representing 63 unique GO IDs (Table S5). However, based on
Fisher’s exact test, only 24 terms were significantly enriched in
MTZR (Table 5). Genes involved in GTP binding and proteolysis
were the most highly enriched, followed by genes associated with
cysteine-type peptidase activity, small GTPase-mediated signal
transduction, oxidoreductase activity, protein kinase activity, and
electron carrier activity. Roughly, the enriched terms could be
classified into four functional categories, namely (1) nucleotide
binding, (2) metabolism, (3) oxidative stress response, and (4)
signal transduction.
Only a fraction of the differentially expressed genes in
MTZR (about 5%) encoded for membrane proteins, based on
positive results for transmembrane and signal peptide predictions
(Table S6). Only 21 genes (14.8%) contained at least one
transmembrane domain. Eleven of these were upregulated, while
10 were downregulated. Proteins encoded by 25 genes (17.6%)
also had predicted signal peptides. Only seven genes have both
transmembrane domains and signal peptides. Only one, however,
was annotated as tyrosine kinase (EHI_118410), while the rest
were all genes for HPs.
Most of the modulated genes were encoded on different
scaffolds. Thirty-four genes (30.6% of EHI-probe sets), however,
formed 15 sets of dyads or triads that occupied the same contig
(Table S7). Included were genes for four AIG1 family proteins
(EHI_126550, EHI_126560, EHI_176700, EHI_176580) and two
Ras family proteins (EHI_045450, EHI_045600). In four sets of
genes, the members were found to be located on opposite strands,
but the regulation of their expression was the same and their fold-
changes were comparable. For some genes found on the same
strand, the distance between the genes was less than 1 kb. It was
therefore possible for these genes to be co-regulated by the same
transcription factor.
Functional Analysis
To study further the relationship between the expression of some
of themodulated genes inMTZRwith drug resistance, generation
of stable transformants overexpressing HA-tagged HP1, ISF1,
ISF2, and ISF4 was performed (Figure 4A). The mRNA level of
these proteins was estimated by qRT-PCR. The levels of mRNA of
HP1 and ISFs were about 5.5 or 2.5 to 3 fold, respectively, higher
in MTZR compared to their expression in HM-1 transfected
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TABLE 2 | List of annotated genes that were upregulated in MTZR by >3 fold compared to HM-1.
Probe Set ID NCBI RefSeq Gene name P-value Fold-change
EHI_164190_at XM_001913665.1 DNA polymerase, putative 2.80E-03 12.9
EHI_025710_at XM_644279.1 Iron-sulfur flavoprotein, putative 4.50E-05 11.6
522.m00018_at XM_643100.1 AIG1 family protein 6.50E-04 11.5
EHI_189960_at XM_647238.1 ADP-ribosylation factor 1, putative 9.20E-04 7.2
EHI_026000_s_at XM_643099.1 AIG1 family protein, putative 2.60E-03 6.5
EHI_138480_at XM_650038.1 Iron-sulfur flavoprotein, putative 6.50E-04 6.3
EHI_073980_s_at XM_648468.1 Serine-rich 25 kDa antigen protein 1.10E-02 6.2
EHI_022270_s_at XM_644761.1 Iron-sulfur flavoprotein 1.60E-02 5.5
EHI_129890_at XM_646723.1 Type A flavoprotein, putative 1.00E-02 5.4
EHI_022600_s_at XM_643169.1 Iron-sulfur flavoprotein 1.40E-02 5.4
EHI_181710_s_at XM_001914510.1 Iron-sulfur flavoprotein, putative 1.30E-02 5.3
82.m00157_s_at XM_648374.1 Surface antigen ariel1 6.80E-03 5.3
EHI_096770_at XM_650580.1 Acetyltransferase, putative 1.30E-02 4.9
EHI_072960_s_at XM_001914217.1 dUTP nucleotidohydrolase domain protein 3.20E-02 4.9
EHI_067720_s_at XM_643101.1 Iron-sulfur flavoprotein, putative 5.30E-04 4.8
EHI_072000_s_at XM_001913846.1 Serine-rich 25 kDa antigen protein, putative 9.40E-03 4.8
EHI_103260_s_at XM_001913434.1 Iron-sulfur flavoprotein 2.30E-02 4.5
82.m00164_s_at XM_648353.1 Serine-rich 25 kDa antigen protein 4.10E-02 4.1
EHI_074750_at XM_644490.1 Ras family GTPase 3.80E-04 3.9
EHI_148550_at XM_652392.1 Protein tyrosine kinase domain-containing protein 4.10E-02 3.8
432.m00028_at XM_643464.1 AIG1 family protein 2.70E-04 3.7
EHI_075660_at XM_643678.1 CAAX prenyl protease, putative 1.70E-04 3.6
EHI_075150_at XM_643772.2 NAD-specific glutamate dehydrogenase, putative 6.10E-03 3.6
EHI_126550_at XM_643463.2 AIG1 family protein, putative 2.00E-03 3.5
EHI_082060_at XM_646822.1 Leucine rich repeat protein, BspA family 1.00E-02 3.4
36.m00218_s_at XM_649994.1 Truncated ABC transporter, putative 4.80E-02 3.3
EHI_147020_at XM_644619.1 Ser/thr protein phosphatase family protein 9.30E-04 3.3
EHI_092100_at XM_649470.1 Chitinase, putative 4.10E-02 3.2
EHI_045450_at XM_652204.1 Ras family GTPase 8.70E-04 3.1
EHI_029620_s_at XM_642949.1 Aldose reductase, putative 1.20E-03 3.1
EHI_118410_at XM_644811.1 Tyrosine kinase, putative 7.20E-03 3.1
EHI_075640_at XM_001914030.1 Protein phosphatase domain-containing protein 2.10E-02 3.1
EHI_045600_at XM_648507.1 Ras family protein 2.30E-02 3.1
EHI_126560_at XM_001914189.1 AIG1 family protein, putative 1.40E-02 3.1
EHI_091450_at XM_645308.2 Cysteine protease, putative 9.00E-04 3.0
with mock vector (pEhEx-HA). Transformants cultured with
10µM G418 were challenged with MTZ for 48 h (Figure 4B).
The highest concentration shown was based on the IC50 of MTZ
against HM-1, performed under the same conditions (6.5µM).
No significant difference in percent survival was observed
at all concentrations tested between the overexpressors and
control (Figure 4B). Neither was significant difference in survival
against hydrogen peroxide, observed, among the transformants
(Figure 4C).
Discussion
Differences in MTZR Generation in This Study
and Previous Works
Currently, only 4 studies have been published regarding
E. histolytica and its response to or resistance to MTZ
(Samarawickrema et al., 1997; Wassmann et al., 1999; Leitsch
et al., 2007; Tazreiter et al., 2008). These studies either exposed
wild-type cells to serum level concentrations of the drug
(70–100µM) or generated drug resistant trophozoites, similar
to what we did in this study. However, the MTZ concentrations
used in these studies and ours differ, which might explain some
of the differences observed. The concentration used here is
slightly higher compared to those used by Samarawickrema
et al. 10µM (Samarawickrema et al., 1997), but significantly
lower than those used by Wassmann et al. 40µM (Wassmann
et al., 1999), Tazreiter et al. 50µM (Tazreiter et al., 2008), and
Leitsch et al. 50µM (Leitsch et al., 2007). Our strain adapted
more quickly to 1µM MTZ compared to the strain used by
Samarawickrema (7 vs. 38 days) but overall the length of time
used to generate MTZR was comparable.
For reasons we do not understand, our attempts to further
increase the level of resistance failed, and no resistance above
the concentration used here could be established. We could
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TABLE 3 | List of annotated genes that were downregulated in MTZR by > 3 fold.
Probe Set ID NCBI RefSeq Gene name P-value Fold-change
EHI_033560_s_at XM_001913757.1 Leucine rich repeat protein 1 2.20E-04 171.4
EHI_077280_s_at XM_649853.2 Leucine rich repeat protein, BspA family 1.70E-04 163.1
371.m00031_s_at XM_643815.1 BspA-like leucine rich repeat protein, putative 3.50E-04 163
628.m00011_at XM_642922.1 AIG1 family protein 4.10E-04 8.4
EHI_160330_s_at XM_001914054.1 Cysteine protease, putative 3.90E-03 7.3
EHI_121160_s_at XM_001914417.1 Cysteine protease, putative 2.20E-03 7.3
EHI_054690_at XM_646973.2 Metal dependent hydrolase, putative 4.90E-04 5.8
EHI_180390_at XM_648725.1 AIG1 family protein, putative 2.40E-03 5.0
EHI_174230_s_at XM_647412.2 S-adenosylmethionine synthetase 5.40E-03 4.1
EHI_176700_at XM_001914268.1 AIG1 family protein, putative 1.00E-02 4.1
EHI_179060_at XM_651187.2 Glycosyltransferase 9.10E-03 3.6
EHI_176580_at XM_643164.1 AIG1 family protein, putative 5.90E-04 3.5
EHI_090260_at XM_645039.1 Competence/damage-inducible protein, putative 6.80E-04 3.4
EHI_020250_at XM_643256.1 Lecithin:cholesterol acyltransferase protein 7.30E-03 3.3
2.m00624_s_at XM_652243.1 Protein kinase, putative 3.20E-02 3.3
EHI_006140_at XM_648345.1 Rho guanine nucleotide exchange factor, putative 3.00E-02 3.2
EHI_026360_s_at XM_650291.1 Phosphoserine aminotransferase, putative 6.30E-03 3.2
554.m00020_s_at XM_643035.1 AIG1 family protein, putative 3.00E-03 3.0
EHI_067220_at XM_647568.1 Rho family GTPase 1.90E-03 3.0
EHI_061760_at XM_643432.1 Protein folding regulator 2.00E-02 3.0
TABLE 4 | qRT-PCR validation of selected genes from our microarray data.
Probe set ID Gene name Fold change by Microarray Fold change by qRT-PCR Regulation
EHI_096770_at Acetyltransferase, putative 4.9 4.6 Upregulated
EHI_176700_at AIG1 family protein, putative 4.1 5.1 Downregulated
EHI_126550_at AIG1 family protein, putative 3.5 5.1 Upregulated
EHI_164190_at DNA polymerase, putative 12.9 2.5 Upregulated
EHI_006850_at Hypothetical protein 1 36.9 57.8 Upregulated
EHI_165190_at Hypothetical protein 2 27.1 16.3 Upregulated
EHI_127670_at Hypothetical protein 3 17 25.2 Downregulated
EHI_087210_at Hypothetical protein 4 8.9 22.5 Upregulated
EHI_054690_at Metal dependent hydrolase, putative 5.8 15.4 Downregulated
EHI_138480_at Iron-sulfur flavoprotein, putative (ISF1) 6.3 5.8 Upregulated
EHI_025710_at Iron-sulfur flavoprotein, putative (ISF2) 11.6 15.8 Upregulated
EHI_129890_at Type A flavoprotein, putative 5.4 3.8 Upregulated
EHI_022600_s_at Iron-sulfur flavoprotein (ISF4) 5.4 8.1 Upregulated
EHI_075150_at NAD-specific glutamate dehydrogenase, putative 3.6 16.8 Upregulated
EHI_147020_at Ser/thr protein phosphatase family protein 3.3 1.9 Upregulated
EHI_118410_at Tyrosine kinase, putative 3.1 2.3 Upregulated
not culture MTZR consistently at drug concentrations higher
than 12µM. In contrast, strains of Trichomonas and Giardia
can be readily adapted to grow at 584µM and 115µM MTZ,
respectively (Kulda et al., 1984; Townson et al., 1992). Our
results are therefore consistent with previous reports indicating
that MTZ resistant strains are more difficult to generate
in E. histolytica (Samarawickrema et al., 1997). While the
concentration we used is several times lower than serum levels
after MTZ treatment (Van Oosten et al., 1986), the changes we
observed may still provide insights as to what occurs in the
parasite in vivo. It was previously reported that in an abscess,
parasites encounter significantly lower levels of drug than those
found in the serum as drug penetration is limited by poor
perfusion and mechanical barriers such as fibrin clots and the
abscess wall (Sirinek, 2000).
Decrease in Growth and Reversibility of
Resistance in MTZR
Formation of drug resistance is often accompanied by fitness
costs (Andersson and Hughes, 2010). One particular cost,
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TABLE 5 | List of GO terms that were significantly enriched in MTZR.
GO ID GO Name Aspect Count p-value
GO:0005525 GTP binding Function 14 3.95E-06
GO:0005622 Intracellular Component 11 8.89E-03
GO:0006508 Proteolysis Process 10 2.78E-08
GO:0007264 Small GTPase mediated signal transduction Process 8 4.58E-05
GO:0008234 Cysteine-type peptidase activity Function 8 5.09E-09
GO:0016491 Oxidoreductase activity Function 7 2.06E-05
GO:0008152 Metabolic process Process 6 5.52E-03
GO:0004713 Protein tyrosine kinase activity Function 5 5.20E-10
GO:0006508 Proteolysis Process 4 1.34E-02
GO:0009055 Electron carrier activity Function 4 9.26E-05
GO:0015031 Protein transport Process 3 3.99E-03
GO:0003887 DNA-directed DNA polymerase activity Function 2 2.06E-02
GO:0004222 Metalloendopeptidase activity Function 2 1.54E-03
GO:0005089 Rho guanyl-nucleotide exchange factor activity Function 2 4.95E-02
GO:0005886 Plasma membrane Component 2 5.95E-04
GO:0006260 DNA replication Process 2 2.66E-02
GO:0006520 Cellular amino acid metabolic process Process 2 1.84E-03
GO:0008408 3′-5′ exonuclease activity Function 2 7.91E-04
GO:0010181 FMN binding Function 2 3.29E-03
GO:0035023 Regulation of Rho protein signal transduction Process 2 4.95E-02
GO:0004648 O-Phospho-L-serine:2-oxoglutarate aminotransferase activity Function 1 5.39E-03
GO:0006564 L-Serine biosynthetic process Process 1 5.39E-03
GO:0006913 Nucleocytoplasmic transport Process 1 5.39E-03
GO:0008483 Transaminase activity Function 1 3.71E-02
GO:0050662 Coenzyme binding Function 1 4.23E-02
reduction in growth rate, is the main parameter that determines
the rate by which resistance develops and level of resistance
reached. Similar to resistant strains previously generated
(Samarawickrema et al., 1997; Wassmann et al., 1999), the
doubling time of MTZR was longer compared to HM-1.
Fitness cost in growth associated with drug resistance are well
documented inmammalian cells, e.g., lymphoma and cancer cells
(Lee, 1993; Bishop et al., 2001). It should be noted, however, that
the growth kinetics of MTZR in the absence of drug pressure
improved over time. This indicates that some of the drug-
selection-induced changes developed by MTZR were temporal
and reversible. This also indicates that cells in the culture may
have varying degrees of resistance. In addition, MTZR (−)
that was re-exposed to MTZ showed significantly lower growth
compared to MTZR, but slightly higher compared to HM-1,
which may indicate that some drug-selection-induced changes
in MTZR were still operative even after the removal of drug
pressure.
Cross-Resistance in MTZR
The resistance level displayed by MTZR is significantly lower
compared to previous reports: the IC50 value of 12µM in this
study compared to 40µM in the previous study (Samuelson,
1999; Wassmann et al., 1999). However, its survival in otherwise
lethal concentration of MTZ for long periods of incubation, does
indicate reduced sensitivity and resistance. The cross-resistance
of MTZR to ornidazole and tinidazole is not surprising,
because both are 5-nitroimidazoles like MTZ. It is therefore
likely that their mode of action and mechanism of resistance
were similar (Pasupuleti et al., 2014). T. vaginalis isolates that
were characterized as having very high resistance to MTZ were
similarly insensitive to tinidazole (Narcisi and Secor, 1996). In
the case of paromomycin, emetine, chloroquine, and hydrogen
peroxide, it is possible that the reduced sensitivity was nonspecific
and could be due to an increased capacity of MTZR to deal with
stress. Studies have shown that cell lines resistant to one drug
are often cross-resistant to closely related drugs or to unrelated
compounds when their mode of action is the same or when they
carry membrane alterations (Upcroft and Upcroft, 1993).
Decreased Adhesion, Phagocytosis, Cytolysis,
and Virulence in MTZR
In E. histolytica, establishment and outcome of infection depend
heavily on adhesive and invasive capacity (Flores-Romo et al.,
1997). Recently, drug resistance has been shown to modulate
these factors and vice versa (Giha et al., 2006). The decreased
rate of adhesion observed inMTZR indicated that MTZ selection
negatively affected the synthesis or expression of surface adhesion
molecules. While other studies have shown that cell adhesion
is a key determinant in drug resistance (Shain and Dalton,
2001), this apparently was not the case in MTZ resistance.
Inhibition of adherence in this parasite has previously been
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FIGURE 4 | (A) qRT-PCR measurement of transfected genes in HP1-HA,
ISF1-HA, ISF2-HA, and ISF4-HA showed overexpression of the genes. Fold
changes relative to pEhEx-HA are shown. (B) MTZ challenge of the
transformants. Transformants cultured with 10µM G418 were challenged with
MTZ for 48 h. (C) Hydrogen peroxide challenge of the transformants. Indicated
transformants were cultured with 25–1600µM hydrogen peroxide for 4 h.
shown to decrease host cell cytotoxicity (Ravdin et al., 1985)
and experimental evidence strongly suggests the involvement of
surface adhesins in phagocytosis (Heron et al., 2011). As shown in
the results, MTZR also had decreased cytopathy and phagocytosis
(Figures 2A,C). The decreased band intensity for CP1 and CP2
in the zymogram may partially explain this phenotype. CP1 has
been shown to be upregulated in a mouse model of amebic
colitis following invasion (Gilchrist et al., 2006), while CP2
has been reported to contribute to intestinal damage and liver
abscess formation (Hellberg et al., 2001). Our microarray data,
however, did not show any significant repression of these genes,
except for two uncharacterized CPs that were repressed by more
than 7 folds. These CPs had high similarity (81%) to CP7 (also
called EhCP-B1) based on amino acid sequence (Tillack et al.,
2007). No significant change was observed in the expression
of the genes known to be involved in the inactivation and
intracellular trafficking of CPs such as intrinsic inhibitors of CPs
(Sato et al., 2006) and cysteine protease binding protein family
1 (Nakada-Tsukui et al., 2012) and other lysosomal hydrolase
carriers (Furukawa et al., 2012, 2013; Marumo et al., 2014).
It is also possible, however, that resistance to MTZ may not
necessarily result to decreased virulence in vivo.
Implications from Transcriptomic Profiling of
MTZR
Our transcriptomic profiling suggests that the transcriptomic
changes we observed in MTZR strain cultured with MTZ were a
combination of the changes responsible for MTZ resistance and
those associated with the adaptation to stresses caused by the
exposure to MTZ. However, we believe that among the observed
changes, the changes that were specific to MTZR strain with
MTZ and absent in HM-1 with MTZ were responsible, at least in
part, for resistance, rather than adaptation. This is based on the
following observations: the transcriptomic profile of E. histolytica
HM-1 cultured with MTZ was remarkably different from that of
MTZR strain cultured with MTZ, while MTZR strain cultured
with or without MTZ showed similar transcriptomic profiles.
In other words, a larger number of common changes in gene
expression were identified between MTZR strain cultured with
MTZ and those without MTZ when compared between MTZR
strain cultured with MTZ and HM-1 cultured with MTZ.
GO enrichment of MTZR-associated transcriptomic changes
revealed regulation of genes encoding for proteins potentially
involved in nucleotide binding, metabolism, oxidative stress
response, and signal transduction. These are apparently the
processes most influenced by MTZ resistance. However, since
most of the genes are without GO annotations, it is likely
that additional processes are involved. When we examined the
genomic locations of these genes, we found that 30% of them
formed dyads or triads that occupied the same contig. While
some genes forming dyads and triads are apart by more than
10 kb, the distance between some of the adjacent genes in dyads
and triads was less than 1 kb. Thus, co-expression of some genes
in dyads and triads in MTZR could be attributed to a shared
regulatory system.
Consistent with previous findings, no significant difference in
PFOR mRNA levels was observed between MTZR and HM-1
(Samarawickrema et al., 1997; Wassmann et al., 1999; Tazreiter
et al., 2008). This observation couldmean 3 things. First, it’s likely
that the level of resistance achieved in this study was not sufficient
to downregulate PFOR, although a similar finding was reported
in strains resistant to 40µM MTZ (Wassmann et al., 1999).
Second, since E. histolytica lacks pyruvate dehydrogenase (Clark
et al., 2007; Tazreiter et al., 2008) or pyruvate decarboxylase
(Lo and Reeves, 1978), the significance of PFOR cannot be
overstated. The lack of an alternative enzyme to compensate for
its downregulation makes this enzyme difficult to repress without
severe consequences to the ameba. Third, in contrast to Giardia
and Trichomonas, lack of PFOR downregulation may indicate
the existence of an alternative mechanism for MTZ resistance in
this parasite. It should be noted, however, that clinically resistant
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isolates of Trichomonas have been reported with no decrease in
PFOR activity (Müller and Gorrell, 1983).
Two previous studies have reported the upregulation of
Fe-SOD and downregulation of Fdx in the MTZ resistant ameba
(Samarawickrema et al., 1997; Wassmann et al., 1999). In the
previous work, fold changes were determined based on enzyme
activity assay or northern blot (Samarawickrema et al., 1997;
Wassmann et al., 1999). Disparity, however, between changes
in mRNA abundance and enzyme activity have been reported,
and in some cases, increases in enzyme activity can exceed those
of mRNA abundance (Glanemann et al., 2003). Interestingly,
the lack of Fe-SOD modulation in cells exposed to MTZ was
also reported by Tazreiter et al. (2008). On the contrary, in this
work, neither gene was modulated significantly. It is possible that
similar to PFOR, differences in resistance levels could explain
the lack of modulation in the levels of Fe-SOD and Fdx. Other
studies also indicated that Fe-SOD and Fdx are not tightly
associated with MTZ resistance. It was shown that parasites
in which Fdx was repressed did not display full resistance to
MTZ (Rasoloson et al., 2002) and in bacteria, increased SOD
activity was not always associated with MTZ resistance (Smith
and Edwards, 1995).
In this study, genes involved in nucleic acid synthesis and
binding, stress response, metabolism, and vesicular trafficking
were mostly affected in MTZR. The significance of these genes
relative to phenotypic changes and drug resistance will be
discussed here through their known roles in E. histolytica or in
other organisms, in regulating key cell functions. One should also
note that since only a single MTZ resistant line was analyzed in
this study, it is possible that MTZ resistance can be also conferred
by the mechanisms that are independent of those described in
this study.
Nucleic Acid Synthesis and Binding
In prokaryotes, upregulation of DNA polymerases imparts
plasticity to their genome, allowing them to adapt in unfavorable
environmental conditions (Joseph et al., 2006). It has been
suggested that pathogenic bacteria utilize this adaptation to
develop resistance against therapeutic agents (Karpinets et al.,
2006). Since it has been shown that primary effect of MTZ
is rapid inhibition of DNA replication (Ludlum et al., 1988;
Sisson et al., 2000; Leitsch et al., 2007), the upregulation of
a DNA polymerase (EHI_164190) in this study may indicate
that this mode of action is operative in MTZ resistance. One
hypothetical protein identified in this study (HP1, EHI_006850)
has some similarity to zinc finger proteins, which are known
to be involved in DNA recognition, RNA packaging, and
transcriptional activation (Laity et al., 2001). It has an NAD+
binding pocket and a tetrachlorodibenzo-p-dioxin (TCDD)-
inducible poly(ADP-ribose) polymerase (PARP)-like domain
that is involved in the attachment of ADP-ribose units to
DNA-binding proteins (Ma et al., 2001). It’s also known to
be a regulatory component induced by DNA damage and an
enzyme involved in DNA repair (Nguewa et al., 2006; Marchler-
Bauer et al., 2011). The dUTP nucleotidohydrolase (EHI_072960)
upregulated in MTZR may be involved in the removal of dUTP
from the dNTP pool, de novo biosynthesis of dTTP, and DNA
replication as reported (Richards et al., 1984; Gadsden et al.,
1993). In cancer cells, high level of dUTPase is implicated
as a mechanism of resistance to chemotherapy (Ladner et al.,
2000).
Stress Response
ISFs that were modulated in MTZR are part of family of redox-
active proteins mainly found in anaerobic prokaryotes (Andrade
et al., 2005). In NCBI, 18 ISF genes are annotated in the E.
histolytica genome, although 50% of these are identical proteins
(http://www.ncbi.nlm.nih.gov/). In this study 7 ISF probe sets
were upregulated by at least 4 folds inMTZR. The overexpression
of ISF1 (EHI_138480) was also observed in HM-1 (+), while ISF2
was upregulated in both MTZR (−) and HM-1 (+). These 2 ISFs
were upregulated in HM-1 (+) by least 20 folds, compared to
6 to 11 folds in MTZR, hinting that these genes are involved
in stress response. These two genes were also induced in E.
histolytica cultured under L-cysteine deprived and oxidative
stress conditions (Vicente et al., 2009; Husain et al., 2011), but
were downregulated in a mouse model of intestinal amebiasis
(Gilchrist et al., 2006). Our findings together with these reports
suggest that induction of these ISFs, particularly ISF1, is an
adaptation that may enhance survival when cells experience
environmental stress.
Metabolism
Several metabolic genes were upregulated in MTZR. NAD-
specific glutamate dehydrogenase (EHI_075150) catalyzes the
oxidative deamination of glutamate to α-ketoglutarate using
NAD as cofactor (Plaitakis and Zaganas, 2001; Girinathan et al.,
2014). Most likely, its upregulation is a part of stress response.
In humans, its activity is regulated through ADP-ribosylation,
and interestingly, Arf1 (EHI_189960) was also upregulated in
this study (Herrero-Yraola et al., 2001). Chitinase (EHI_092100)
(Escueta- De Cadiz et al., 2013) was also upregulated in MTZR
and MTZR (−) by at least 3 folds, although its precise role in
drug resistance is not known. In plants, its upregulation plays
a defensive role against toxins and antibiotics (Gooday, 1999).
Aldose reductase (EHI_029620), on the other hand, can reduce
a broad spectrum of substrates including cytotoxic aldehydes
(Ramana, 2011). Its upregulation in human liver cancer cells was
associated with resistance to daunorubicin and was confirmed by
sensitizing cells to the drug by the addition of aldose reductase
inhibitors (Lee et al., 2001).
The decrease in cell growth observed in MTZR may
be partially explained by the repression of phosphoserine
aminotransferase (EHI_026360) (Ali and Nozaki, 2006;
Mishra et al., 2010), which catalyzes the conversion of
3-phosphohydroxypyruvate to L-phosphoserine, the second
step of phosphorylated serine biosynthetic pathway (Ali and
Nozaki, 2006). L-serine has a well-recognized role in cell
proliferation, providing precursors for amino acids, protein
synthesis, and nucleotide synthesis (Nozaki et al., 2005;
Tabatabaie et al., 2010). The downregulation of this enzyme,
therefore, may contribute to the decreased growth rate. The
repression of lecithin: cholesterol acyltransferase (EHI_020250)
may also be associated with decreased growth rate, because the
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enzyme is crucial in the maturation, remodeling, andmetabolism
of high density lipoprotein, HDL (Calabresi et al., 2011).
BspA1 Gene Family
Several genes encoding for leucine-rich repeat (LRR) proteins
of the BspA family were also modulated in MTZR, and
were the most downregulated genes with fold changes of
more than 150. LRR is known to provide a structural
framework for the formation of protein-protein interactions
and serve as recognition motifs for surface proteins (Kobe and
Kajava, 2001). BspA family protein was originally identified
in Bacteroides forsythus and the LRR motifs of the BspA
protein have been linked to cell binding to components of
the extracellular matrix (Sharma et al., 1998). It is therefore
possible that their downregulation may partially explain the
reduced adhesion seen in MTZR. It was previously shown
that an LRR BspA family protein in E. histolytica was located
primarily on the plasma membrane, although it did not
show whether the protein was involved in surface interactions
(Davis et al., 2006).
AIG1 Gene Family
The E. histolytica AIG1 gene family consists of 47 members
(Biller et al., 2010), and in this study 10 genes were found
to be differentially expressed by 3 to 11 folds. Members of
this protein family contain a domain found in Arabidopsis
protein AIG1, which is likely involved in plant recognition
and resistance to bacterial pathogens (Reuber and Ausubel,
1996). In E. histolytica, however, some AIG proteins appear
to be linked with virulence. Comparative genomic analysis
of Japanese clinical isolates indicated that an AIG family
protein (EHI_176590) and the region around it were uniquely
present in KU50, a strain isolated from a diarrheic patient, but
absent in a non-pathogenic isolate called KU27 (Nakada-Tsukui
et al., unpublished data). Interestingly, the same gene was
downregulated by 2.7 folds in MTZR, and two adjacent
genes encoding for AIG family proteins (EHI_176580 and
EHI_176700) were also repressed by 3 to 4 folds. A previous
study also reported the upregulation of an AIG family protein
(EHI_180390) in a pathogenic strain of E. histolytica (Biller et al.,
2010), although here the same gene was downregulated by 5
folds. It is therefore possible that the downregulation of these
AIG family proteins might be related to the decrease in MTZR’s
cytopathogenicity.
Overall, we believe that these transcriptional changes
participate in a global regulatory response resulting to the fitness
costs and adaptive responses we observed inMTZR. The fact that
more genes were upregulated than downregulated also suggests
that increasing the amount of cellular components that play roles
in stress response, DNA repair and others, is more important
in developing low levels of resistance to MTZ than repression
of proteins involved in activating the drug. Indeed, the most
profound difference we observed between MTZR and HM-1 was
the upregulation of genes for several ISF proteins. It should be
noted, however, that more than half of the genes reported in
this study are hypothetical. It is also likely that the effects of the
repressed genes, although fewer in number, are more important
in explaining the growth defect.
Functional Analysis of Potential Resistance
Genes
In this study, we examined possible role of genes encoding
HP1 and several ISF proteins in MTZ resistance. However, their
episomal transfection and overexpression did not confer MTZ
resistance to the extent observed in MTZR. Thus, at present,
direct causal connection between HP1 and ISF overexpression
and MTZ resistance has not been demonstrated. It is likely that
in E. histolytica, resistance to the drug is multi-factorial in nature
and requires the global regulation of genes involved in several key
cell processes and not just DNA repair and stress response.
In conclusion, here we described the biological state of
E. histolytica that was selected for MTZ resistance in vitro.
Phenotypic and transcriptional profiling revealed fitness costs
and adaptive responses that we could associate with drug
resistance. Some of the consequences of resistance included
decreased cell growth and virulence, which have significant
implications on host-pathogen interaction and infection
outcome. Comparative transcriptional analysis, on the other
hand, revealed genes not previously associated with MTZ
resistance in this parasite. The list of differentially transcribed
genes also did not indicate in MTZR a reduced capacity to
activate MTZ, but hinted on adaptations to tolerate the lethal
effects of MTZ. Identifying the signaling mediators for the
proteins that these genes encode, however, requires further
investigation. Finally, while our data showed that high levels
of MTZ resistance cannot be readily induced in vitro, the data
presented here may still help researchers in better understanding
the mechanisms involved should clinical cases of high levels of
resistance are reported in the future.
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